Additionally, in osteosarcoma cells, it also possesses the anti-metastatic activity by down-regulating the MMP-2 and MMP-9 secretions and increasing the TIMP-1 and TIMP-2 expressions via Akt-dependent and p38 pathways [37,38,40,41,42]. Here, MMP9 is linked to osteosarcoma.